Deal Chess

Ask a founder why a raise went badly and you'll usually hear about the market, the numbers, or the one investor who wasted three months. You'll rarely hear that their own moves were out of order — that they were playing stages they didn't know were there.

Every financing has stages. Venture, growth equity, debt, and the sale of a company all run through a sequence, and the sequence has rules about what happens when.

M&A makes the stages explicit. There's a teaser, a CIM, management presentations, indications of interest, business diligence, a letter of intent, confirmatory diligence, signing, close. Everyone at the table knows which stage they're in because the stages are written down.

A venture raise has much of the same architecture and almost none of the signposts. No teaser, no CIM, no formal IOI. The stages are still real, and the order still matters, but nobody hands the founder the map. So founders skip stages without knowing they exist — and when the raise struggles, the post-mortem blames the market.

I've seen the pattern from a lot of angles. Across four exits, roughly $1 billion raised, and close to three dozen companies bought or sold, I've come to think about financings less as negotiations than as processes with distinct phases. By the time you're negotiating, much of the outcome has already been determined.

Chess is the closest picture of it. Not because a raise is adversarial — today's investor may join your board next quarter, and tactics that work in a one-off game can be destructive in a repeated one. The analogy works because chess has phases with distinct jobs, and strong players can lose without making a single obvious blunder. They misplay the opening and reach the middle game a half-step behind, holding a position that can't produce what they need. A raise is often lost the same way: in a phase other than the one where it eventually feels lost. Three phases. Each has a job. Founders get into trouble when they play the wrong one.

The opening

The opening is everything before the first meeting: the story, the elevator pitch, the investor presentation, the target list, the financial model, the introductions, and the answers to the questions that are coming. In chess, the opening is development — getting your pieces onto squares where they can work before contact. In a raise, the first meetings are where the opening ends, not where it begins.

Three pieces of work define it.

Know your weaknesses before they're found. There is no perfect company, and investors know it. The work of the opening is finding your own soft spots — the churn cohort, the customer concentration, the hole in the management team — and deciding in advance which you fix, which you explain, and which you disclose. A weakness you name is a fact. The same weakness discovered during diligence becomes a question about you.

Have the answers ready. Preparation is what makes speed possible, and speed itself conveys information. When a difficult question comes back the same day, answered precisely with the supporting detail behind it, the investor sees a company that is prepared and a process that may already be active. Maybe the question has been asked before, maybe the founder anticipated it; either way, the response tells the investor something beyond the answer itself. You can't manufacture that in the afternoon when the question arrives. You produce it because the work was done when nothing seemed to be happening. Fast responses aren't just diligence hygiene — they're visible evidence of an opening played well.

Align your story and your numbers. The narrative you tell and the numbers you hand over have to describe the same company. When they diverge, diligence becomes a translation project, and translation projects expose seams. A weak quarter is a business problem. A model that reveals the story was never internally consistent is a credibility problem. Investors can tolerate the first much more easily than the second.

The first meetings close the opening. Your goal is to get investors to lean in, to ask questions, to pursue the company. Your goal is not (reasonably) to close the raise. To do so, founders communicate three things: whether the pain is large and urgent, whether the differentiation is large and sustainable, and whether this team fits this problem. Everything else, including the product itself, is secondary which is where founders often lose the first meeting. They lose by talking about the wrong thing: starting with the product and the technology before the problem, the market, the differentiation, and the evidence have landed. Detail is the reward for a thesis the investor has already accepted. Lead with the detail and you're answering a question the investor hasn't yet decided to ask.

The middle game

The middle game is managing the field: several investors, at different stages, moving at different speeds, forming different views. It's also where founders tend to become passive — meetings taken as offered, materials sent on request, investors setting the cadence. Two valuable things are available in this phase, and both are easy to miss.

The first is tempo. In chess, tempo is about initiative: who's forcing whom to respond. Run the field well and investors are responding to your process — you control the sequence, the pace, and when different investors reach their decision points. There is art in the timing, in who you see first, who you hold back, when you accelerate someone and when you allow more time, but the default is speed. You want several credible investors reaching decisions within roughly the same window, not evaluating the company sequentially at their leisure. The calendar communicates whether a process has momentum without the founder ever saying so. That's competitive tension in its early form.

The second is signal. Let investors ask questions. Being ready to answer quickly is not the same as answering before you're asked; if you pre-empt every concern, you throw away the information the questions themselves would have given you. The pattern of questions tells you where an investor believes the risk sits. Repeated questions about retention may point toward product or product-market-fit concerns; questions about sales cycles may indicate go-to-market risk; persistent questions about the founding team's background may reveal doubts about execution. The precise mapping varies, but the principle doesn't: what investors ask tells you what they're underwriting.

A repeated question is usually an objection. If an investor asks essentially the same thing twice — differently phrased, perhaps in a later meeting — your first answer didn't resolve the concern. Saying it again more forcefully treats a failed answer as a hearing problem. Instead, figure out what failed. Was the evidence insufficient? Was the framing wrong for the way this investor thinks about the risk? Or is the concern legitimate and your original answer really a deflection? Those require different responses — more evidence, a better frame, or an honest concession followed by a plan. Founders lose rounds to objections they were told about twice.

A badly played middle game creates the round that won't die and won't close. Conversations stay warm, nobody quite says no, and every few weeks there's another meeting, another request, another month of numbers to scrutinize. The biggest cost isn't usually valuation. It's the loss of your alternative. A dragging process burns the runway that funded your ability to walk away, and by the time terms finally arrive, the founder may have substantially less leverage than when the process began.

The end game

By the time a term sheet arrives, much of the outcome has already been set. The end game is largely about collecting what the earlier phases created.

The single biggest factor is whether you have a real alternative. A second term sheet — even a somewhat worse one — changes the nature of the first negotiation: the question shifts from "Will the founder accept our deal?" toward "Might we lose this deal?" "We could always raise later" is not an alternative. The test is simple: if the first deal disappeared tomorrow, is there another path you would actually take?

That's why competitive tension is earned rather than manufactured. It's created in the opening through preparation and credibility, and built in the middle game by running multiple serious investors toward decisions in the same window. Only then can it be spent in the end game. Arrive with one interested party and you probably didn't lose the negotiation — you lost leverage earlier.

The next question is what you're optimizing for, and the answer isn't automatically valuation. A company raising from strength may reasonably emphasize price, although partner quality and governance still matter. A company under pressure has a different objective function: certainty may matter more, speed may matter more, structural terms may matter more, and valuation may become the variable you're willing to give. Founders can destroy enormous value by holding out for the right price at the wrong moment — burning runway until the deal they eventually accept is worse than the one they rejected earlier. The mistake isn't insufficient toughness. It's optimizing the wrong variable.

And valuation is only one part of the economics. Liquidation preference and participation, the size and treatment of the option pool, board composition, protective provisions and other structural terms can matter as much as — sometimes more than — a modest difference in headline valuation. They matter well before an exit: a preference stack changes the expected value of common equity, an option pool created pre-money shifts dilution toward existing holders, and board composition determines who decides the next hard thing. The number everyone talks about is often not the only number that matters. It's also why the weakness you chose to disclose in the opening ages better than the one a buyer's counsel surfaces here — by the end game, a fact you volunteered is settled, while one that's found is repriced.

One rule governs the whole end game: the counterparty isn't leaving. A sale is usually a terminating transaction; a financing is the beginning of a relationship. The investor may join your board, participate in the next financing, recruit executives, influence strategic decisions, and sit across from you during the worst quarter you'll have. That changes what winning means. Extracting every possible concession in the current transaction can be a very expensive way to begin a ten-year relationship.

The stages of a venture raise aren't printed anywhere. There's no CIM, no IOI, no LOI with the gate named across the top. But the stages are real, they're ordered, and the person across the table may have run the sequence a hundred times. The founder's job is to play a game whose board they can't see as if they can. That starts with knowing it has one.